Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

(2015)   Oncotarget

Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes

(2010) Francesca Orso et al.   BMC GENOMICS

A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation

(2010) Yuri Frosi et al.   JOURNAL OF CELL BIOLOGY

Mitogen-Inducible Gene-6 Is a Multifunctional Adaptor Protein with Tumor Suppressor-Like Activity in Papillary Thyroid Cancer

(2010) Chi-Iou Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma

(2009) M. W. VanBrocklin et al.   CANCER RESEARCH

Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis

(2009) N. Jin et al.   DEVELOPMENT

Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma

(2009) Markus Reschke et al.   HEPATOLOGY

Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease

(2009) J.-W. Jeong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead

(2008) Antonello Mai et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY